¹⁷⁷Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer

Figure 7

Treatment response evaluated using the ⁶⁸Ga-PSMA-11-PET/CT diagnostic images (right and left anterior images) after the therapy with ¹⁷⁷Lu-iPSMA (middle: anterior and posterior images at 24 h after the first cycle with ¹⁷⁷Lu-iPSMA) (patient 7, partial response in soft tissue lesions but progressive disease in bone).